Multicenter,Open-Label Study to Evaluate the Efficacy and Safety of Perampanel as MonotherapyorFirst Adjunctive Therapy in SubjectsWith Partial Onset Seizures With or Without Secondarily Generalized Seizures or With Primary Generalized Tonic-Clonic